Bausch Health Companies Inc (NYSE:BHC)
| 7.23 Delayed Data As of Mar 24 |  -0.05 / -0.69%Today’s Change | 4.00 Today|||52-Week Range 23.97 | +15.13% Year-to-Date |
Latest BHC News | Press Releases
| Implied Volatility Surging for Bausch Health (BHC) Stock Options Mar 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.28 |
| Today’s open | 7.19 |
| Day’s range | 7.02 - 7.25 |
| Volume | 4,417,946 |
| Average volume (3 months) | 5,514,970 |
| Market cap | $2.6B |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +76.47% |
| Earnings growth (this year) | +3.37% |
| Earnings growth (next 5 years) | -5.21% |
| Revenue growth (last year) | -3.68% |
| P/E ratio | NM |
| Price/Sales | 0.28 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RAREUltragenyx Pharmaceu... | +0.75 | +2.03% |
| RVNCRevance Therapeutics... | +0.26 | +0.83% |
| SAGESAGE Therapeutics In... | +0.51 | +1.20% |
| GLPGGalapagos NV | -0.07 | -0.19% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $8.1B |
| Annual profit (last year) | -$225.0M |
| Net profit margin | -2.77% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Laval, Quă©bec |
Forecasts
